Section 13
Chapter 12,048

Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) study

Dalby, M.; Montalescot, G.; Bal dit Sollier, C.; Vicaut, E.; Soulat, T.; Collet, J.Philippe.; Choussat, Rémi.; Gallois, V.; Drobinski, Gérard.; Drouet, L.; Thomas, D.

Journal of the American College of Cardiology 43(2): 162-168


ISSN/ISBN: 0735-1097
PMID: 14736431
DOI: 10.1016/j.accreview.2004.03.050
Accession: 012047070

OBJECTIVES The present study hypothesis was that eptifibatide offered further antiplatelet efficacy above clopidogrel in non-ST-elevation myocardial infarction (NSTEMI) patients before an expeditive coronary intervention.

PDF emailed within 0-6 h: $19.90